Issue Highlights
Adding the ‘medicines’ back into personalized medicine to improve cancer treatment outcomes
Commentary on the medico-legal aspects of prescribing vitamin D
A systematic review of the role of community pharmacies in improving the transition from secondary to primary care
Biosimilar: what it is not
Pharmacokinetics and pharmacodynamics of rilotumumab: a decade of experience in preclinical and clinical cancer research
Calcitonin gene-related peptide in the joint: contributions to pain and inflammation
Integration of PKPD relationships into benefit–risk analysis
Development of anti-migraine therapeutics using the capsaicin-induced dermal blood flow model
Pharmacokinetics and safety of subcutaneous rituximab plus fludarabine and cyclophosphamide for patients with chronic lymphocytic leukaemia
Improved informed consent documents for biomedical research do not increase patients' understanding but reduce enrolment: a study in real settings
Drug disposition and modelling before and after gastric bypass: immediate and controlled-release metoprolol formulations
Physiologically-based pharmacokinetic modeling of renally excreted antiretroviral drugs in pregnant women
Population pharmacokinetics of oseltamivir in non-pregnant and pregnant women
Pharmacokinetics and pharmacodynamics of PF-05231023, a novel long-acting FGF21 mimetic, in a first-in-human study
Exposure–effect relationship of mycophenolic acid and prednisolone in adult patients with lupus nephritis
Favipiravir inhibits acetaminophen sulfate formation but minimally affects systemic pharmacokinetics of acetaminophen
No relevant pharmacokinetic interaction between pantoprazole and mycophenolate in renal transplant patients: a randomized crossover study
Human hepatocyte assessment of imatinib drug–drug interactions – complexities in clinical translation
Interindividual epigenetic variation in ABCB1 promoter and its relationship with ABCB1 expression and function in healthy Chinese subjects
In vivo assessment of the metabolic activity of CYP2D6 diplotypes and alleles
Effect of carboxylesterase 1 c.428G > A single nucleotide variation on the pharmacokinetics of quinapril and enalapril
The FNTB promoter polymorphism rs11623866 as a potential predictive biomarker for lonafarnib treatment of ovarian cancer patients
Pharmacogenetic testing prior to carbamazepine treatment of epilepsy: patients' and physicians' preferences for testing and service delivery
Impact of visceral leishmaniasis and curative chemotherapy on cytochrome P450 activity in Brazilian patients
Measuring anticholinergic drug exposure in older community-dwelling Australian men: a comparison of four different measures
Impact of treatment algorithms on the prescribing of antithrombotic therapy in patients with suspected acute coronary syndrome – a prospective audit
Population pharmacokinetics of midazolam and its metabolites in overweight and obese adolescents
Population pharmacokinetics and dosing optimization of teicoplanin in children with malignant haematological disease
Risk of hip/femur fractures during the initiation period of α-adrenoceptor blocker therapy among elderly males: a self-controlled case series study
Cardiovascular drugs and erectile dysfunction – a symmetry analysis
Metformin versus insulin for gestational diabetes mellitus: a meta-analysis
Re: The medico-legal aspects of prescribing vitamin D
Sulfasalazine disposition in a subject with 376C>T (nonsense mutation) and 421C>A variants in the ABCG2 gene
Reply to ‘Effects of food on pharmacokinetics of immediate release oral formulations’
Effects of food on pharmacokinetics of immediate release oral formulations